Drug stocks have been on fire lately, and over the past few weeks, the two leading covid-19 vaccine makers, Pfizer (PFE) – Get Free Report and Moderna (MRNA) – Get Free Report, have surg...
Tag: Pharmaceuticals
Strep A antibiotics prices, shortages hit drugstores amid UK outbreak
Drugstores are warning of major shortages of key antibiotics used to treat Strep A, as cases rise in the U.K. Marko Geber | Digitalvision | Getty Images LONDON — Drugstores in Britain are warning of s...
Clovis Enters Bankruptcy With Deal to Sell Cancer-Drug Candidate to Novartis
Clovis Oncology Inc., maker of the ovarian and prostate cancer drug Rubraca, filed for bankruptcy over the weekend with a proposed deal in hand to sell its rights to a cancer therapy under development...
Horizon Therapeutics, Coupa Software, Rivian, and More Stock Market Movers
This copy is for your personal, non-commercial use only. To order presentation-ready copies for distribution to your colleagues, clients or customers visit http://www.djreprints.com. https://www.barro...
Novozymes and Chr. Hansen agree deal to merge
Danish biotechnology companies Novozymes AS NZYM.B, -13.67% and Chr. Hansen Holding AS CHR, +23.64% said Monday they have agreed to merge, creating a biological solutions provider with combined annual...
Paccar, Deere, and 10 More Companies That Raised Their Stock Dividends This Week
Text size Paccar said it will boost its regular dividend to 25 cents a share. Dreamstime Carrier Global, Deere , Zoetis , and Paccar were among the many large U.S. companies that declared dividend inc...
CVS Wants to Be a Healthcare Provider. So Why Doesn’t It Have Any Doctors?
Late last year, CVS Health CEO Karen Lynch unveiled a new strategy: Rather than remain simply a pit stop for toilet paper and flu shots, CVS stores would become a place that Americans—particularly old...
BNP Paribas studied 100 years of market crashes — here’s what it says is coming next
Oops. Stocks fell through a key support on Tuesday and it looks like some recent momentum has now petered out. The new line in the sand for the S&P 500 SPX, -1.44% seems to be 3,900. Whether Santa...
What to watch for as J&J gets ready to spin off its consumer unit
Johnson & Johnson (JNJ) is preparing next year to spin off its consumer health unit into a publicly traded company separate from its pharmaceutical and medical technology operations. Ahead of the ...
Biden administration will end monkeypox public health emergency
People line up to get a monkeypox vaccination at a new walk-up monkeypox vaccination site at Barnsdall Art Park on Tuesday, Aug. 9, 2022 in Hollywood, CA. Brian Van Der Brug | Los Angeles Times | Get...
This trader sees a 43% drop for the S&P 500 and says to take shelter in these ETFs instead.
A day after the Dow DJIA, -0.11% climbed out of bear territory on hopeful comments by Fed Chairman Jerome Powell, stocks look ready to rethink on that optimsim, even after fresh inflation data showed ...
World Health Organization to rename monkeypox as mpox
The name mpox, otherwise known as Mpox, was chosen after the WHO launched a public consultation process earlier this year. Orlando Sentinel | Tribune News Service | Getty Images The World Health Organ...
Omicron BQ variants dominant, XBB circulating at low level
A person receives a coronavirus disease (COVID-19) test as the Omicron coronavirus variant continues to spread in Manhattan, New York City, U.S., December 22, 2021. Andrew Kelly | Reuters The omicron ...
Big Pharma Stocks Are Breaking Out. Here Are Some Winners.
Big pharma stocks are trying to break out to new heights. They have reported more-than-satisfactory earnings and are expecting further progress on new pipelines of drugs. These stocks had been outpe...
Mindfulness meditation reduces anxiety as much as common antidepressant drug: study
Mindfulness meditation is as effective at reducing anxiety as a commonly prescribed antidepressant, according to a study published in a major journal on Wednesday. The study, led by researchers at Geo...
Pfizer Stock’s Post-Covid Future Looks Healthy
These reports, excerpted and edited by Barron’s, were issued recently by investment and research firms. The reports are a sampling of analysts’ thinking; they should not be considered the views or rec...
AARP-Branded Medicare Drug Plan Is Too Costly for Many Retirees, Critics Say
The AARP name has become a marketing juggernaut among baby boomers, with the group’s nearly 38 million members receiving offers for AARP-branded health, life and auto insurance, and discounts on cellp...
4 of our stocks are in the news. Here’s the Club’s take on each development
Four of our Club holdings — Costco Wholesale (COST), Amazon (AMZN), Humana (HUM) and Bausch Health (BHC) — were in the news Thursday. Here’s how we feel about the developments. Costco The news: ...
The Race To The Bottom In The Chinese Pharmaceutical Market Reinforces The Need To Market In The United States
while new drugs may be approved in China, unless they have unique mechanisms of action, they may simply join a race to the bottom in terms of domestic reimbursement. Hence the increasing trend for Chi...
CVS Health reports Q3 earnings, opioid settlement
Rafael Henrique | Lightrocket | Getty Images CVS Health reported third quarter earnings Wednesday morning that beat Wall Street’s expectations. Here’s how the pharmacy giant performed com...
Eli Lilly CEO on guidance cut, potential obesity drug, Alzheimer’s study
Eli Lilly (LLY) CEO David Ricks on Tuesday expressed optimism around the drugmaker’s innovation pipeline Tuesday, a stance we share despite the Club holding’s cluttered quarterly report is...
AbbVie Stock Slips as Sales Miss Expectations And Bigger Challenges Await.
Stock in AbbVie slipped after the drug company reported a higher profit than expected, while sales fell short. The revenue shortfall may have reminded investors of a challenge AbbVie (ticker: ABBV) fa...
Billionaire Mark Cuban Makes a Strong Statement
Mark Cuban has made his decision. And it is certain that this one will delight the many fans of the hit TV show Shark Tank, of which he is one of the pillars. The successful entrepreneur’s fut...
10 Dividend Aristocrat stocks expected by analysts to rise up to 54% in 2023
Stocks of companies that raise dividends consistently have outperformed during this year’s bear market. Below is a screen showing which stocks are analysts’ favorites for next year among an expanded l...